United States · FDA National Drug Code directory
ALVIMOPAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0254-3012_d43941f1-7b52-4e7a-a560-9a8e28a7ac65
- Product NDC
- 0254-3012
- Form
- CAPSULE
- Composition / generic term
- ALVIMOPAN
- Labeler
- Par Health USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230503
- Source listing expiry
- 20271231
Source-listed ingredients
- ALVIMOPAN — 12 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (0254-3012-55) / 5 CAPSULE in 1 BLISTER PACK · 0254-3012-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →